President Trump signs an executive order to freeze federal employee pay in early-2019.

Rose Prince

2019-01-06 08:39:00 Sun ET

President Trump signs an executive order to freeze federal employee pay in early-2019. Federal employees face furlough or work without pay due to the government shutdown. Trump then pours salt into the wound by issuing an executive order that freezes federal pay for around 2 million public employees and contractors in early-2019. In effect, this executive order cancels the 2% pay increase for 2 million non-military federal workers, whereas, the same executive order has no impact on the 2.6% pay increase for military servants and soldiers.

This strategic move expands the prior Trump claim that he *would be proud to shut down the government for better border security*. Specifically, Trump demands $5 billion public finance for the southern border wall. The wall can help improve the domestic quality of health care, education, and many other public services for U.S. residents. So the $5 billion border wall tax becomes essential for overall domestic welfare in America.

On the other side of the same story, however, this executive order serves as a key Trump tactic that tilts Congress toward political compromise. The tense negotiation contributes to the Trump presidential campaign promise of better border security although most Americans blame President Trump for the government shutdown.

 


If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.

Blog+More

The Economist Intelligence Unit (EIU) continues to track major business risks in light of volatile stock markets.

Fiona Sydney

2019-01-11 10:33:00 Friday ET

The Economist Intelligence Unit (EIU) continues to track major business risks in light of volatile stock markets.

The Economist Intelligence Unit (EIU) continues to track major business risks in light of volatile stock markets, elections, and geopolitics. EIU monitors g

+See More

Michael Sandel analyzes what money cannot buy in stark contrast to the free market ideology of capitalism.

Daisy Harvey

2023-06-21 12:32:00 Wednesday ET

Michael Sandel analyzes what money cannot buy in stark contrast to the free market ideology of capitalism.

Michael Sandel analyzes what money cannot buy in stark contrast to the free market ideology of capitalism. Michael Sandel (2013)   What money

+See More

Mario Draghi declares the ECB agreement on a thorny set of revisions to Basel 3.

Rose Prince

2017-11-25 06:34:00 Saturday ET

Mario Draghi declares the ECB agreement on a thorny set of revisions to Basel 3.

Mario Draghi, President of the European Central Bank, heads the international committee of financial supervisors and has declared their landmark agreement o

+See More

AYA Analytica financial health memo (FHM) blog post and podcast content curation with wise words of wisdom

Daisy Harvey

2019-04-30 07:15:00 Tuesday ET

AYA Analytica financial health memo (FHM) blog post and podcast content curation with wise words of wisdom

Through our AYA fintech network platform, we share numerous insightful posts on personal finance, stock investment, and wealth management. Our AYA finte

+See More

What are our proprietary alpha stock signals?

Andy Yeh Alpha

2020-09-11 10:22:00 Friday ET

What are our proprietary alpha stock signals?

AYA fintech network platform provides proprietary alpha stock signals and personal finance tools. In recent times, we have completed our fresh website up

+See More

Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties.

Rose Prince

2018-10-15 09:33:00 Monday ET

Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties.

Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties such as cardiovascular medications an

+See More